Jim Simons Cyma Bay Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.63 - $24.47 $587,295 - $1.14 Million	46,500 Added 40.99%	159,950 $3.78 Million
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $1.7 Million - $2.76 Million	-156,570 Reduced 57.98%	113,450 $1.69 Million
Q2 2023 Aug 11, 2023	SELL	$7.47 - $10.95 $1.58 Million - $2.32 Million	-211,480 Reduced 43.92%	270,020 $2.96 Million
Q1 2023 May 12, 2023	SELL	$5.88 - $9.59 $143,472 - $233,996	-24,400 Reduced 4.82%	481,500 $4.2 Million
Q4 2022 Feb 13, 2023	BUY	$3.22 - $6.27 $48,622 - $94,677	15,100 Added 3.08%	505,900 $3.17 Million

Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $65,981 - $101,235	-23,820 Reduced 4.63%	490,800 $1.72 Million
Q2 2022 Aug 12, 2022	BUY	$1.72 - $3.39 $94,746 - $186,738	55,085 Added 11.99%	514,620 $1.52 Million
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $675,644 - $887,850	243,915 Added 113.12%	459,535 $1.43 Million
Q4 2021 Feb 11, 2022	SELL	$3.23 - $4.6 $959,216 - $1.37 Million	-296,971 Reduced 57.94%	215,620 $729,000
Q3 2021 Nov 12, 2021	SELL	$3.47 - $4.42 $984,192 - $1.25 Million	-283,629 Reduced 35.62%	512,591 $1.87 Million
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $370,135 - $462,199	-93,943 Reduced 10.55%	796,220 $3.47 Million
Q1 2021 May 13, 2021	BUY	$4.23 - $6.55 $2.03 Million - $3.15 Million	480,443 Added 117.26%	890,163 $4.04 Million
Q4 2020 Feb 10, 2021	BUY	$5.73 - $9.03 $1.44 Million - $2.26 Million	250,800 Added 157.82%	409,720 $2.35 Million
Q3 2020 Nov 13, 2020	BUY	$3.32 - $7.24 $233,728 - $509,696	70,400 Added 79.53%	158,920 $1.15 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $4.25 $124,813 - $376,210	88,520 New	88,520 $309,000
Q1 2020 May 14, 2020	SELL	$1.25 - $2.02 $531,050 - $858,176	-424,840 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.33 - $5.93 $511,943 - $2.28 Million	384,920 Added 964.23%	424,840 $833,000
Q3 2019 Nov 13, 2019	BUY	$5.12 - $7.21 $204,390 - $287,823	39,920 New	39,920 $204,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account